TOP 20 Top 20 Biopharma Deal Terminations of 2021 Based on Total Deal ValueByPrince GiriMarch 10, 20220Comments
VIEWPOINTS PharmaShots Interview: Guardant Health’s Kathryn Lang Shares Insight on SHIELD Blood Test for Colorectal CancerBySenior EditorMarch 9, 20220Comments
VIEWPOINTS PharmaShots Interview: SalioGen Therapeutics’ Ray Tabibiazar Shares Insights on Gene Coding PlatformBySenior EditorMarch 8, 20220Comments
THOUGHTSPOT After Effects of Russia – Ukraine Conflict Over Pharma and Life Sciences IndustryBySenior EditorMarch 2, 20220Comments
VIEWPOINTS PharmaShots Interview: Clario’s Joyce Suhy Shares Insights on PET Imaging Clinical TrialsBySenior EditorMarch 1, 20220Comments
VIEWPOINTS PharmaShots Interview: Zai Lab’s Jonathan Wang Shares Insights on KarXT (xanomeline-trospium) for the Treatment of Schizophrenia And PsychosisBySenior EditorFebruary 28, 20220Comments
VIEWPOINTS PharmaShots Interview: Boston Scientific’s Ron Morton Shares Insights on the Rezūm Water Vapor TherapyBySenior EditorFebruary 24, 20220Comments
